PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
36.26%
Some net income increase while VUZI is negative at -75.00%. John Neff would see a short-term edge over the struggling competitor.
8.39%
D&A growth well above VUZI's 2.72%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-451.16%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.20%
SBC growth while VUZI is negative at -10.05%. John Neff would see competitor possibly controlling share issuance more tightly.
177.20%
Well above VUZI's 86.16% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-1054.08%
Both yoy AR lines negative, with VUZI at -791.87%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-152.26%
Both reduce yoy inventory, with VUZI at -286.79%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
8027.73%
AP growth well above VUZI's 128.64%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
163.98%
Growth well above VUZI's 272.11%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-149.60%
Negative yoy while VUZI is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
71.11%
Operating cash flow growth above 1.5x VUZI's 32.42%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-38.85%
Both yoy lines negative, with VUZI at -133.77%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
95.94%
Acquisition growth of 95.94% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-120.96%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-45.45%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-171.81%
Both yoy lines negative, with VUZI at -343.84%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-102.90%
Both yoy lines negative, with VUZI at -255.27%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-10.17%
We cut debt repayment yoy while VUZI is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
38900.00%
Lower share issuance yoy vs. VUZI's 105866.58%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-2.88%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.